2m 2m 2m 2m 2m 2m 2m
TELOMIR PHARMA (TELO)
NASDAQ
$1.27+$0.08 (+7.20%)
Price as of Oct 02, 2026 7:36 PM EDT- $80.5MMarket Cap
- -15.71%1-Year Change
- BiotechnologyIndustry
TELOMIR PHARMA (TELO)
$1.27+$0.08 (+7.20%)
TELO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.18 | ||
Change | +$0.01 (+0.85%) | ||
Open | $1.17 | ||
High | $1.22 | ||
Low | $1.17 | ||
Previous Close | $1.17 | ||
Volume | 76,587 | ||
30-Day Average Volume | 73,325 | ||
1-Week Change | -4.07% | ||
1-Month Change | 5.36% | ||
1-Year Change | -15.71% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 68.8M | ||
Total Assets | $5.4M | ||
Market Cap | $80.5M | ||
Enterprise Value | $75.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$47.8M | ||
Free Cash Flow | -$1.0M | ||
EBIT | -$47.8M | ||
EBITDA | -$47.8M | ||
Net Working Capital | $5.0M | ||
EPS | -$0.79 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -79 | ||
Price/Operating Cash Flow | -79 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue